Cargando…

Efficacy of a Validated Yoga Protocol on Dyslipidemia in Diabetes Patients: NMB-2017 India Trial

Background: Dyslipidemia is considered a risk factor in Type 2 diabetes mellitus (T2DM) resulting in cardio-vascular complications. Yoga practices have shown promising results in alleviating Type 2 Diabetes pathology. Method: In this stratified trial on a Yoga based lifestyle program in cases with T...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagarathna, Raghuram, Tyagi, Rahul, Kaur, Gurkeerat, Vendan, Vetri, Acharya, Ishwara N., Anand, Akshay, Singh, Amit, Nagendra, Hongasandra R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963794/
https://www.ncbi.nlm.nih.gov/pubmed/31614579
http://dx.doi.org/10.3390/medicines6040100
_version_ 1783488363427266560
author Nagarathna, Raghuram
Tyagi, Rahul
Kaur, Gurkeerat
Vendan, Vetri
Acharya, Ishwara N.
Anand, Akshay
Singh, Amit
Nagendra, Hongasandra R.
author_facet Nagarathna, Raghuram
Tyagi, Rahul
Kaur, Gurkeerat
Vendan, Vetri
Acharya, Ishwara N.
Anand, Akshay
Singh, Amit
Nagendra, Hongasandra R.
author_sort Nagarathna, Raghuram
collection PubMed
description Background: Dyslipidemia is considered a risk factor in Type 2 diabetes mellitus (T2DM) resulting in cardio-vascular complications. Yoga practices have shown promising results in alleviating Type 2 Diabetes pathology. Method: In this stratified trial on a Yoga based lifestyle program in cases with Type 2 diabetes, in the rural and urban population from all zones of India, a total of 17,012 adults (>20 years) of both genders were screened for lipid profile and sugar levels. Those who satisfied the selection criteria were taught the Diabetes Yoga Protocol (DYP) for three months and the data were analyzed. Results: Among those with Diabetes, 29.1% had elevated total cholesterol (TC > 200 mg/dL) levels that were higher in urban (69%) than rural (31%) Diabetes patients. There was a positive correlation (p = 0.048) between HbA1c and total cholesterol levels. DYP intervention helped in reducing TC from 232.34 ± 31.48 mg/dL to 189.38 ± 40.23 mg/dL with significant pre post difference (p < 0.001). Conversion rate from high TC (>200 mg/dL) to normal TC (<200 mg/dL) was observed in 60.3% of cases with Type 2 Diabetes Mellitus (T2DM); from high LDL (>130 mg/dL) to normal LDL (<130 mg/dL) in 73.7%; from high triglyceride (>200 mg/dL) to normal triglyceride level (<200 mg/dL) in 63%; from low HDL (<45 mg/dL) to normal HDL (>45 mg/dL) in 43.7% of T2DM patients after three months of DYP. Conclusions: A Yoga lifestyle program designed specifically to manage Diabetes helps in reducing the co-morbidity of dyslipidemia in cases of patients with T2DM.
format Online
Article
Text
id pubmed-6963794
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-69637942020-01-27 Efficacy of a Validated Yoga Protocol on Dyslipidemia in Diabetes Patients: NMB-2017 India Trial Nagarathna, Raghuram Tyagi, Rahul Kaur, Gurkeerat Vendan, Vetri Acharya, Ishwara N. Anand, Akshay Singh, Amit Nagendra, Hongasandra R. Medicines (Basel) Article Background: Dyslipidemia is considered a risk factor in Type 2 diabetes mellitus (T2DM) resulting in cardio-vascular complications. Yoga practices have shown promising results in alleviating Type 2 Diabetes pathology. Method: In this stratified trial on a Yoga based lifestyle program in cases with Type 2 diabetes, in the rural and urban population from all zones of India, a total of 17,012 adults (>20 years) of both genders were screened for lipid profile and sugar levels. Those who satisfied the selection criteria were taught the Diabetes Yoga Protocol (DYP) for three months and the data were analyzed. Results: Among those with Diabetes, 29.1% had elevated total cholesterol (TC > 200 mg/dL) levels that were higher in urban (69%) than rural (31%) Diabetes patients. There was a positive correlation (p = 0.048) between HbA1c and total cholesterol levels. DYP intervention helped in reducing TC from 232.34 ± 31.48 mg/dL to 189.38 ± 40.23 mg/dL with significant pre post difference (p < 0.001). Conversion rate from high TC (>200 mg/dL) to normal TC (<200 mg/dL) was observed in 60.3% of cases with Type 2 Diabetes Mellitus (T2DM); from high LDL (>130 mg/dL) to normal LDL (<130 mg/dL) in 73.7%; from high triglyceride (>200 mg/dL) to normal triglyceride level (<200 mg/dL) in 63%; from low HDL (<45 mg/dL) to normal HDL (>45 mg/dL) in 43.7% of T2DM patients after three months of DYP. Conclusions: A Yoga lifestyle program designed specifically to manage Diabetes helps in reducing the co-morbidity of dyslipidemia in cases of patients with T2DM. MDPI 2019-10-11 /pmc/articles/PMC6963794/ /pubmed/31614579 http://dx.doi.org/10.3390/medicines6040100 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Nagarathna, Raghuram
Tyagi, Rahul
Kaur, Gurkeerat
Vendan, Vetri
Acharya, Ishwara N.
Anand, Akshay
Singh, Amit
Nagendra, Hongasandra R.
Efficacy of a Validated Yoga Protocol on Dyslipidemia in Diabetes Patients: NMB-2017 India Trial
title Efficacy of a Validated Yoga Protocol on Dyslipidemia in Diabetes Patients: NMB-2017 India Trial
title_full Efficacy of a Validated Yoga Protocol on Dyslipidemia in Diabetes Patients: NMB-2017 India Trial
title_fullStr Efficacy of a Validated Yoga Protocol on Dyslipidemia in Diabetes Patients: NMB-2017 India Trial
title_full_unstemmed Efficacy of a Validated Yoga Protocol on Dyslipidemia in Diabetes Patients: NMB-2017 India Trial
title_short Efficacy of a Validated Yoga Protocol on Dyslipidemia in Diabetes Patients: NMB-2017 India Trial
title_sort efficacy of a validated yoga protocol on dyslipidemia in diabetes patients: nmb-2017 india trial
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963794/
https://www.ncbi.nlm.nih.gov/pubmed/31614579
http://dx.doi.org/10.3390/medicines6040100
work_keys_str_mv AT nagarathnaraghuram efficacyofavalidatedyogaprotocolondyslipidemiaindiabetespatientsnmb2017indiatrial
AT tyagirahul efficacyofavalidatedyogaprotocolondyslipidemiaindiabetespatientsnmb2017indiatrial
AT kaurgurkeerat efficacyofavalidatedyogaprotocolondyslipidemiaindiabetespatientsnmb2017indiatrial
AT vendanvetri efficacyofavalidatedyogaprotocolondyslipidemiaindiabetespatientsnmb2017indiatrial
AT acharyaishwaran efficacyofavalidatedyogaprotocolondyslipidemiaindiabetespatientsnmb2017indiatrial
AT anandakshay efficacyofavalidatedyogaprotocolondyslipidemiaindiabetespatientsnmb2017indiatrial
AT singhamit efficacyofavalidatedyogaprotocolondyslipidemiaindiabetespatientsnmb2017indiatrial
AT nagendrahongasandrar efficacyofavalidatedyogaprotocolondyslipidemiaindiabetespatientsnmb2017indiatrial